ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.63
0.12%
US Tech 100
21,156.80
-0.70%
S&P 500
6,101.24
-0.29%
US Dollar vs CAD
1.44878
0.00%
Bitcoin
105,011.63
0.27%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSXV

  6. Medexus Pharmaceuticals Inc (MDP) Share Price

Medexus Pharmaceuticals Inc

Medexus Pharmaceuticals Inc (MDP)

Medexus Pharmaceuticals Inc
7.75
0.00
(0.00%)
Closed January 26 3:00PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
7.75
Bid
7.80
Ask
7.85
Volume
-
0.00 Day's Range 0.00
7.75 52 Week Range 7.75
Market Cap
189.55M
Previous Close
7.75
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
24,458,000
Dividend Yield
-
PE Ratio
-566.67
Earnings Per Share (EPS)
-0.01
Revenue
113.05M
Net Profit
-214k

About Medexus Pharmaceuticals Inc

Sector
Pharmaceutical Preparations
Industry
Blank Checks
Website
www.medexus.com
Headquarters
Bolton, Gbr
Founded
2013
Medexus Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the TSX Venture Exchange with ticker MDP. The last closing price for Medexus Pharmaceuticals was $7.75. Over the last year, Medexus Pharmaceuticals shares have traded in a share price range of $ 7.75 to $ 7.75.

Medexus Pharmaceuticals currently has 24,458,000 shares outstanding. The market capitalization of Medexus Pharmaceuticals is $189.55 million. Medexus Pharmaceuticals has a price to earnings ratio (PE ratio) of -566.67.

Ask ADVFN Intelligence (AI)

MDP Latest News

More News

Complete Response Letter Received from FDA for Treosulfan

TORONTO and CHICAGO and WEDEL, Germany, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) and medac GmbH (“medac”) announced...

August 03 2021
GlobeNewswire Inc.

Medexus Appoints New Chief Financial Officer

TORONTO and CHICAGO, July 19, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) is pleased to announce the appointment of Marcel Konrad...

July 19 2021
GlobeNewswire Inc.

Medexus Pharmaceuticals and medac GmbH enter into Licensing Agreement for First-in-Class Conditioning Agent, Treosulfan, in C...

TORONTO and CHICAGO and WEDEL, Germany, July 12, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSX: MDP) (OTCQX: MEDXF) today announced that it has entered...

July 12 2021
GlobeNewswire Inc.

Medexus Receives Notice of Compliance to Commercialize Treosulfan in Canada

TORONTO and CHICAGO, June 28, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSX: MDP) (OTCQX: MEDXF) today announced that it has received a Notice of...

June 28 2021
GlobeNewswire Inc.

Medexus Revenue Increases 43.5% to a Record US$79.7 Million for Fiscal 2021

Transformative licensing agreement for treosulfan in the U.S. completed February 2, 2021 Cash and cash equivalents of $18.7 million and available liquidity of $24.8 million at March 31, 2021...

June 16 2021
GlobeNewswire Inc.

Medexus Announces Graduation to the Toronto Stock Exchange

TORONTO and CHICAGO and MONTREAL, June 15, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSXV:MDP) (OTCQX: MEDXF) announced today that it has received final...

June 15 2021
GlobeNewswire Inc.

Medexus to Present at Raymond James Human Health Innovation Conference

TORONTO, CHICAGO and MONTREAL, June 14, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it...

June 14 2021
GlobeNewswire Inc.

Medexus Schedules Fiscal Year 2021 Conference Call

TORONTO and CHICAGO and MONTREAL, June 11, 2021 (GLOBE NEWSWIRE) -- , June 11, 2021 - Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today...

June 11 2021
GlobeNewswire Inc.

Medexus Strengthens Medical Affairs Team in Preparation for Planned Treosulfan Launch

TORONTO, CHICAGO and MONTREAL, June 10, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today announced that it...

June 10 2021
GlobeNewswire Inc.

Medexus Announces Availability of Triamcinolone Hexacetonide in the United States

TORONTO and CHICAGO and MONTREAL, June 09, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it...

June 09 2021
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1007.757.757.7500CS
4007.757.757.7500CS
12007.757.757.7500CS
26007.757.757.7500CS
52007.757.757.7500CS
156007.757.757.7500CS
2604.05109.4594594593.79.751.4279666.84598439CS

MDP - Frequently Asked Questions (FAQ)

What is the current Medexus Pharmaceuticals share price?
The current share price of Medexus Pharmaceuticals is $ 7.75
How many Medexus Pharmaceuticals shares are in issue?
Medexus Pharmaceuticals has 24,458,000 shares in issue
What is the market cap of Medexus Pharmaceuticals?
The market capitalisation of Medexus Pharmaceuticals is CAD 189.55M
What is the 1 year trading range for Medexus Pharmaceuticals share price?
Medexus Pharmaceuticals has traded in the range of $ 7.75 to $ 7.75 during the past year
What is the PE ratio of Medexus Pharmaceuticals?
The price to earnings ratio of Medexus Pharmaceuticals is -566.67
What is the cash to sales ratio of Medexus Pharmaceuticals?
The cash to sales ratio of Medexus Pharmaceuticals is 1.07
What is the reporting currency for Medexus Pharmaceuticals?
Medexus Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Medexus Pharmaceuticals?
The latest annual turnover of Medexus Pharmaceuticals is USD 113.05M
What is the latest annual profit for Medexus Pharmaceuticals?
The latest annual profit of Medexus Pharmaceuticals is USD -214k
What is the registered address of Medexus Pharmaceuticals?
The registered address for Medexus Pharmaceuticals is 35 NIXON ROAD, UNIT 1, BOLTON, L7E 1K1
What is the Medexus Pharmaceuticals website address?
The website address for Medexus Pharmaceuticals is www.medexus.com
Which industry sector does Medexus Pharmaceuticals operate in?
Medexus Pharmaceuticals operates in the BLANK CHECKS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ADEAdex Mining Inc
$ 0.01
(100.00%)
1,000
DEALPlaygon Games Inc
$ 0.02
(100.00%)
1.75M
TVC.HThree Valley Copper Corp
$ 0.01
(100.00%)
15.6k
GBUGabriel Resources Ltd
$ 0.01
(100.00%)
167k
MACThemac Resources Group Ltd
$ 0.08
(60.00%)
3k
NAVNAVCO Pharmaceuticals Inc
$ 0.005
(-50.00%)
16.63k
SMAR.PSmartset Services Inc
$ 0.015
(-50.00%)
30k
ETUE2gold Inc
$ 0.005
(-50.00%)
101.7k
DDDMetavista3D Inc
$ 2.30
(-49.45%)
701.59k
MXL.HMX Gold Corp
$ 0.04
(-46.67%)
1.5k
NDANeptune Digital Assets Corp
$ 2.20
(30.18%)
5.15M
BRCBlackrock Silver Corp
$ 0.355
(-11.25%)
3.79M
TDGTDG Gold Corp
$ 0.45
(-1.10%)
3.19M
GPUSAlset AI Ventures Inc
$ 0.14
(-12.50%)
2.79M
PNGKraken Robotics Inc
$ 2.87
(0.35%)
2.69M

Discussion

View Full Feed
BlazingStocks BlazingStocks 40 seconds ago
$ILLR News December 20, 2024

Triller Group Inc. Unveils Bold Vision and Exciting Business Updates During Investor Day
https://finance.yahoo.com/news/triller-group-inc-unveils-bold-140000772.html
ILLR
stervc stervc 3 minutes ago
maryj55555, here with TKMO and its dilution...

I do believe there is some dilution here with TKMO, but I have to say... sometimes dilution is our friend because it gives people a chance to get the last of the cheap shares before a major catalyst is revealed to graduate the stock to th
TKMO
docj docj 6 minutes ago
Anything can happen even for CYDY being on the OTC market. Partial credit to Biostocktraderbyday for this info:

Several biotech companies that initially started as over-the-counter (OTC) stocks or smaller companies have gone on to become major players in the pharmaceutical and biotech
AMGN CYDY EXEL
XMaster2023 XMaster2023 7 minutes ago
Both LP’s know their rights. Can you imagine 35 law firms trying to agree on anything?
NWBO
stervc stervc 8 minutes ago
Chartmaster, here with TKMO...

I took a starter here with TKMO as a "Lotto Play" based on some of the thoughts floating around about what's coming in here and who is coming in here.

v/r
Sterling
TKMO
100lbStriper 100lbStriper 10 minutes ago
this is always good............ https://www.youtube.com/watch?v=Pamx5XMDxeM
NLST
Copilotdog Copilotdog 11 minutes ago
Nobody touching this. Just shut it down. They don't even have the 7m cash anymore. Jeff deposited it into his personal account.
PSYCF
ssc ssc 12 minutes ago
All that effort, all those long-winded posts - so much like dickran. And still overwhelmed by cowardice and fear to answer one simple question:

Why are you dedicating your time here to lie about and attack those who post the facts about erhc and the truth about liar and largest share
ERHE
Bullrunner2 Bullrunner2 12 minutes ago
Amrn should be sold simply because a large pharmaceutical company could turn this into a multi-billion dollar drug within two years, saving millions worldwide. It needs to be released as quickly as possible; the go-it-alone strategy was a mistake from the beginning. I would accept $3 for that reason
AMRN
ollik78 ollik78 14 minutes ago
JZXN Starts again
10$ hopefully 
ATLnsider ATLnsider 14 minutes ago
Congratulations Dr. Linda Liau for being recognized as 1 of the Top Doctors in LA, and in the US and the world, for her work with NWBio in developing DCVax, dendritic cell-based cancer vaccine platform. Her work will help save and extend the lives of millions of cancer patients worldwide:
NWBO
fredscott36 fredscott36 15 minutes ago
.....the FDIC had the last two LIBOR ANTITRUST cases in which to bring the perps in front of a federal jury and get PUNITIVE DAMAGES..........for the little people hurt by the BARBARIC, unconscionable conduct.................

.....FDIC chose our sonterra case, and worked it thru the U
ollik78 ollik78 17 minutes ago
Nice 👍 

VSEE
Spectra777 Spectra777 21 minutes ago
Present S7 Google Meta Text

"Spectra7 is connecting the world of VR. Featured in the leading VR headsets on the market from some of the largest manufacturers."

Here are three improved meta text options for Spectra7's website, tailored to better reflect its focus on acti
SEV
Hoskuld Hoskuld 23 minutes ago
Sab, what credible source estimates 3%-4% likelihood of approval? FWIW, the EMA would not have accepted an MAA with those odds because it would be a waste of everyone's time. The EMA will not accept applications that don't have a serious chance of approval - that is the whole rationale behind the
AVXL
Jake731 Jake731 26 minutes ago
Would you stop crying. Grow a set of balls and wait like the rest of us. If you don't like it ……… leave. 


GOOD MORNING ALL.








TPTW……!!!!!!!
TPTW
CanItBThisEZ2Make CanItBThisEZ2Make 27 minutes ago
BEST SELLERS RANK (BSR) IS 267 22 Estimated Sold on Amazon Since JAN 1 - 1ST Quarter 2025
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value Dec
SRMX
BFarb BFarb 28 minutes ago
Wait for the next pump I guess. If they pull through with a new lease at a different location to start generating these carbon credits and pulling in some licensing money through carbon limit contracts we will see another 1000 percent gain or more. 
DRNK
ksquared ksquared 30 minutes ago
Thanks for the heads up, cap.
Go Commanders!
A.K.A. Go Redskins!
(My sister's family is the Virginia branch of my kinfolk.)

Actually, I don't care who wins...
as long as Philadelphia loses. ;-)

Enjoy th
Patrick Bateman Patrick Bateman 34 minutes ago
What or who is this?
RITE
maryj55555 maryj55555 34 minutes ago
Company sold some more shares?  Idk how 700 m could be retail and the price not go up more - besides the faucet being on still. 

I think even if they do max out the AS, they will run her before any major split is announced. 
TKMO
Midwestrader Midwestrader 34 minutes ago
You back BAGHOLDER BOY?? Though you'd disappeared for good after losing at LEAST $150,000-$200,000 on this "get rich quick" FRAUD.🤣🤪💀

Now this POS SCAM is imploding over non-ending lawsuits and BANKRUPTCY filings. But wait....you bought 150 MILLION SHARES of
INND
Mufaso Mufaso 37 minutes ago
BDX-
How did the syringe business become so concentrated that BDX is 6x the size of the next-biggest player?
I don't know how the syringe business became so concentrated but can make an educated guess or two as I may or may not have been involved in the design/supply of automation lin
BDX

Your Recent History

TSXV
MDP
Medexus Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads